1030 - Association of Female Sex with Mortality in Patients with Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis

Thursday, October 12, 2023

3:27 PM – 3:39 PM US ET

Location: 102 AB

Presenting Author(s)

Annette C. Westgeest, MD

PhD candidate
Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands

Slides

Co-Author(s)

ML

Merel M.C. Lambregts, MD PhD

Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands
RK

Rachel E. Korn, BS

Duke University Medical Center
Durham, North Carolina, United States
MW

Maren E. Webster, BS

Duke University Medical Center
Durham, North Carolina, United States
JK

Jackson L. Kair, BS

Duke University Medical Center
Durham, North Carolina, United States
FR

Felicia Ruffin, MSN

Research Program Leader
Duke University Medical Center
Durham, North Carolina, United States
Joshua B. Parsons, MD, PhD

Fellow
Duke University Medical Center
Durham, North Carolina, United States
Stacey Maskarinec, MD, PHD

Assistant Professor
Duke University Medical Center
Durham, NC, United States
SK

Samantha Kaplan, PhD

Duke University Medical Center
Durham, North Carolina, United States
Md

Mark G. de Boer, MD. PhD. FIDSA.

Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands
Vance G. Fowler, MD, MHS

Professor of Medicine
Duke University Medical Center
Durham, NC, United States
Joshua T. Thaden, MD, PhD (he/him/his)

Assistant Professor
Duke University School of Medicine
Durham, NC, United States

Disclosure(s):

Vance G. Fowler, MD, MHS: Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant (); Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support (); Infectious Diseases Society of America: Honoraria (); MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support (); Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant (); Sepsis diagnostic: Patent pending (); UpToDate: Royalties (); Valanbio and ArcBio: Stock Options ()